Orbisresearch.com has announced the addition of the “Global Drug Delivery Technologies Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
Dallas, U.S.A - April 18, 2018 /MarketersMedia/ —
"Global Drug Delivery Technologies Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally.
The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases. Delivering a drug with the desired release kinetics requires an understanding of the underlying physicochemical properties of the drug, which determine the type of delivery material and drug release mechanism. Numerous parameters need to be considered, and their inter-dependence has to be taken into account to develop successful drug delivery systems for the intended applications. It is important to understand the complexity associated with the development of a drug delivery system that can ultimately be used in human patients.
Ask for PDF Sample ;with Full TOC at http://orbisresearch.com/contacts/request-sample/150608
The report covers the currently available drug delivery technologies and recent advances in the field, with granular analyses of the different types of delivery systems, their advantages, disadvantages and opportunities for future development. The report provides global market forecasts by revenue for the market until 2020. Additionally, forecasts by revenue for key geographical markets and supporting analyses of the main factors driving or restraining growth are included.
The market for drug delivery technology is poised for strong growth in the coming years. Key factors promoting growth include the rapidly expanding injectables market, the growing incidence of chronic diseases and the expected significant increase in the use of complex biologic drugs that necessitate novel delivery systems. Drug delivery companies have had to adapt to challenging times in the same way as pharmaceutical companies have had to over the past decade. These companies have achieved this by adopting new business strategies that allow them to take better control of their commercial and financial future. The report analyzes how business models in this dynamic industry have evolved over the last couple of decades and how new companies with improved product portfolios and propositions are emerging.
Scope Of This Report
- What are the drug delivery technologies used in the market and how have they evolved in recent years?
- What will be the market value, by revenue, of the market over the coming years?
Drivers and restraints in the drug delivery industry:
- What are the most important factors promoting growth in the market at a global level?
- What are the most important factors restraining growth in the market?
- What is the impact of novel delivery systems on the management of a product’s lifecycle?
- Will emerging markets contribute significantly to the growth of the global market?
- How will regulatory- and reimbursement-related challenges hinder the market?
Technologies based on drug vehicle/carriers:
- What are the various advantages, limitations and applications of the currently available drug carriers?
Technologies based on route of administration:
- How can lifecycle management strategies reposition existing drugs by changing their route of administration?
- What are the advantages, limitations and applications of the different drug delivery technologies, based on their route of administration?
- What are the prospects for revenue growth for the latest technologies, including metered-dose inhalers and hydrogels?
Technologies for injectables:
- Which technologies in the injectables market have contributed to overall growth?
- What is the market forecast for needle-free injectors in the coming years?
- What is driving the need for novel delivery systems for injectable drugs?
Key Reasons to Purchase
- Gain insightful analyses and understanding of market dynamics. The report comprehensively describes and assesses the most important factors driving and restraining the drug delivery technology market.
- Evaluate a granular assessment of the pipelines for the various drug delivery technology segments and the prospects and revenue forecasts for the upcoming delivery technologies until 2020.
- Evaluate the strategies and business models used by companies to achieve their full commercial potential.
- Gain insight on upcoming trends and factors influencing the global market for drug delivery technology.
Get More Information & Sample Copy at http://orbisresearch.com/contacts/request-sample/150608
1 Table of Contents
2 Drug Delivery Technologies - An Overview 5
3 Current Drug Delivery Technologies and Recent Developments 12
4 Advances in Injectable Drug Delivery Market 43
5 Evolving Business Models in the Drug Delivery Technologies Market 63
6 Future Outlook for Drug Delivery Technologies 65
7 Bibliography
8 Appendix 70
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas
Phone: +1 (214) 884-6817
For more information, please visit http://orbisresearch.com
Source: MarketersMedia
Release ID: 333051
